30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Omega Therapeutics Inc (OMGA)

Track

Stock chart
Ticker: OMGA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Richard Young
Former board member within 90 days
1 sale — total 100,000 USD
Proposed sale 5 Feb 2025
Value US$959,701.98 | Price 415.10 | Shares 82,395
Planned sale 2 Jun 2023
Value US$4,503,575.12 | Price 488.35 | Shares 8,303
Proposed sale 2 Jun 2023
Value US$4,730,025.98 | Price 302.68 | Shares 14,375
Planned sale 1 May 2023
Value US$40,000.00 | Price 8.00 | Shares 5,000
Proposed sale 1 May 2023
Value US$38,750.00 | Price 7.75 | Shares 5,000
Planned sale 6 Apr 2023
Value US$40,000.00 | Price 8.00 | Shares 5,000
Planned sale 17 Mar 2023
Value US$80,000.00 | Price 8.00 | Shares 10,000
Buy 27 Feb 2023
Value US$7,683,492.72 | Price 5.78 | Shares 1,329,324
Buy 27 Feb 2023
Value US$11,525,239.08 | Price 5.78 | Shares 1,993,986
Planned sale 10 Jan 2023
Value US$160,000.00 | Price 8.00 | Shares 20,000
Planned sale 14 Sep 2022
Value US$80,000.00 | Price 8.00 | Shares 10,000
Buy 3 Aug 2021
Value US$4,999,989.00 | Price 17.00 | Shares 294,117
Buy 3 Aug 2021
Value US$11,249,988.00 | Price 17.00 | Shares 661,764
Buy 3 Aug 2021
Value US$3,749,996.00 | Price 17.00 | Shares 220,588
Buy 3 Aug 2021
Value US$14,875,000.00 | Price 17.00 | Shares 875,000
Buy 3 Aug 2021
Value US$49,997.00 | Price 17.00 | Shares 2,941
Buy 3 Aug 2021
Value US$902,394.00 | Price 17.00 | Shares 53,082
Buy 30 Jul 2021
Value US$1,210,342.50 | Price 16.14 | Shares 75,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-05 2025-02-05 PrS Proposed sale
Richard Young

Former board member within 90 days
82,395
415.10
US$959,702 		82,395 415.10 US$959,702
2023-06-05 2023-06-02 PlS Planned sale
Young Richard A
Non-Executive Director
8,303 +31.4%
488.35
US$4,503,575 		8,303 +31.4% 488.35 US$4,503,575
2023-06-02 2023-06-02 PrS Proposed sale
Young Richard A

Director

Non-Executive Director
14,375
302.68
US$4,730,026 		14,375 302.68 US$4,730,026
2023-05-03 2023-05-01 PlS Planned sale
Young Richard A
Non-Executive Director
5,000 -0.7%
8.00
US$40,000 		5,000 -0.7% 8.00 US$40,000
2023-05-01 2023-05-01 PrS Proposed sale
Young Richard A

Director

Non-Executive Director
5,000
7.75
US$38,750 		5,000 7.75 US$38,750
2023-04-10 2023-04-06 PlS Planned sale
Young Richard A
Non-Executive Director
5,000 -0.7%
8.00
US$40,000 		5,000 -0.7% 8.00 US$40,000
2023-03-20 2023-03-17 PlS Planned sale
Young Richard A
Non-Executive Director
10,000 -1.3%
8.00
US$80,000 		10,000 -1.3% 8.00 US$80,000
2023-02-27 2023-02-27 B Purchase
3.4
Flagship Pioneering Inc.
Large shareholder
1,329,324 +inf%
5.78
US$7,683,493 		1,329,324 +inf% 5.78 US$7,683,493
2023-02-27 2023-02-27 B Purchase
3.4
Flagship Pioneering Inc.
Large shareholder
1,993,986 +36.2%
5.78
US$11,525,239 		1,993,986 +36.2% 5.78 US$11,525,239
2023-01-11 2023-01-10 PlS Planned sale
Young Richard A
Non-Executive Director
20,000 -2.6%
8.00
US$160,000 		20,000 -2.6% 8.00 US$160,000
2022-09-15 2022-09-14 PlS Planned sale
Young Richard A
Non-Executive Director
10,000 -1.3%
8.00
US$80,000 		10,000 -1.3% 8.00 US$80,000
2021-08-05 2021-08-03 B Purchase
3.4
Flagship Pioneering Inc.
Large shareholder
294,117 +22.2%
17.00
US$4,999,989 		294,117 +22.2% 17.00 US$4,999,989
2021-08-05 2021-08-03 B Purchase
3.4
Flagship Pioneering Inc.
Large shareholder
661,764 +13.6%
17.00
US$11,249,988 		661,764 +13.6% 17.00 US$11,249,988
2021-08-05 2021-08-03 B Purchase
3.4
Flagship Pioneering Inc.
Large shareholder
220,588 +2.6%
17.00
US$3,749,996 		220,588 +2.6% 17.00 US$3,749,996
2021-08-03 2021-08-03 B Purchase
3.8
Invus Public Equities, L.P.
Large shareholder
875,000 +62.6%
17.00
US$14,875,000 		875,000 +62.6% 17.00 US$14,875,000
2021-08-03 2021-08-03 B Purchase
2.6
Sawhney Roger

Chief Financial Officer

Officer
2,941 +inf%
17.00
US$49,997 		2,941 +inf% 17.00 US$49,997
2021-08-03 2021-08-03 B Purchase
2.6
BERRY DAVID A
Non-Executive Director
53,082 +inf%
17.00
US$902,394 		53,082 +inf% 17.00 US$902,394
2021-08-03 2021-07-30 B Purchase
3.8
Invus Public Equities, L.P.
Large shareholder
75,000 +inf%
16.14
US$1,210,342 		75,000 +inf% 16.14 US$1,210,342
Explore more

More insider trading research around Omega Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America